These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31868146)

  • 1. Recent Advances in the Development of Macrolide Antibiotics as Antimicrobial Agents.
    Qin Y; Ma S
    Mini Rev Med Chem; 2020; 20(7):601-625. PubMed ID: 31868146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolactin Antibiotics: Amazing Natural Products.
    Ortiz A; Sansinenea E
    Mini Rev Med Chem; 2020; 20(7):584-600. PubMed ID: 31804166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The macrolide antibiotic renaissance.
    Dinos GP
    Br J Pharmacol; 2017 Sep; 174(18):2967-2983. PubMed ID: 28664582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A platform for the discovery of new macrolide antibiotics.
    Seiple IB; Zhang Z; Jakubec P; Langlois-Mercier A; Wright PM; Hog DT; Yabu K; Allu SR; Fukuzaki T; Carlsen PN; Kitamura Y; Zhou X; Condakes ML; Szczypiński FT; Green WD; Myers AG
    Nature; 2016 May; 533(7603):338-45. PubMed ID: 27193679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosome-binding and anti-microbial studies of the mycinamicins, 16-membered macrolide antibiotics from Micromonospora griseorubida.
    Breiner-Goldstein E; Eyal Z; Matzov D; Halfon Y; Cimicata G; Baum M; Rokney A; Ezernitchi AV; Lowell AN; Schmidt JJ; Rozenberg H; Zimmerman E; Bashan A; Valinsky L; Anzai Y; Sherman DH; Yonath A
    Nucleic Acids Res; 2021 Sep; 49(16):9560-9573. PubMed ID: 34417608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature nurtures the design of new semi-synthetic macrolide antibiotics.
    Fernandes P; Martens E; Pereira D
    J Antibiot (Tokyo); 2017 May; 70(5):527-533. PubMed ID: 27899792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The solithromycin journey-It is all in the chemistry.
    Fernandes P; Martens E; Bertrand D; Pereira D
    Bioorg Med Chem; 2016 Dec; 24(24):6420-6428. PubMed ID: 27595539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the field of 16-membered macrolide antibiotics.
    Cui W; Ma S
    Mini Rev Med Chem; 2011 Oct; 11(12):1009-18. PubMed ID: 21861810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrolide-bacterium interaction and its biological basis.
    Goldman RC; Scaglione F
    Curr Drug Targets Infect Disord; 2004 Sep; 4(3):241-60. PubMed ID: 15379734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in screening of natural products for antimicrobial agents.
    Zhou M; Luo H; Li Z; Wu F; Huang C; Ding Z; Li R
    Comb Chem High Throughput Screen; 2012 May; 15(4):306-15. PubMed ID: 22221063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 16-membered macrolide antibiotics: a review.
    Arsic B; Barber J; Čikoš A; Mladenovic M; Stankovic N; Novak P
    Int J Antimicrob Agents; 2018 Mar; 51(3):283-298. PubMed ID: 28668674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of novel bifunctional macrolides.
    Akritopoulou-Zanze I; Phelan KM; Marron TG; Yong H; Ma Z; Stone GG; Daly MM; Hensey DM; Nilius AM; Djuric SW
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3809-13. PubMed ID: 15203167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
    J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
    Fernandes P; Pereira D; Watkins PB; Bertrand D
    J Med Chem; 2020 Jun; 63(12):6462-6473. PubMed ID: 31644280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
    Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN
    Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in metabolic engineering of macrolide antibiotics].
    Hao T; He W
    Sheng Wu Gong Cheng Xue Bao; 2021 May; 37(5):1737-1747. PubMed ID: 34085452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin.
    Furfaro LL; Spiller OB; Keelan JA; Payne MS
    Int J Antimicrob Agents; 2015 Sep; 46(3):319-24. PubMed ID: 26141231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levantilides A and B, 20-membered macrolides from a Micromonospora strain isolated from the Mediterranean deep sea sediment.
    Gärtner A; Ohlendorf B; Schulz D; Zinecker H; Wiese J; Imhoff JF
    Mar Drugs; 2011 Jan; 9(1):98-108. PubMed ID: 21339949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide antibiotics in paediatric infectious diseases.
    Guay DR
    Drugs; 1996 Apr; 51(4):515-36. PubMed ID: 8706592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of macrolides and ketolides: focus on respiratory tract infections.
    Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
    Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.